Trained innate immunity reshapes how innate cells respond to pathogens the body has not previously encountered by producing lasting functional changes in cells such as monocytes, macrophages and natural killer cells. Trained immunity relies on epigenetic reprogramming and metabolic shifts that increase the speed and magnitude of inflammatory responses, so an unrelated bacterial, fungal or viral challenge can be controlled more effectively but with a trade-off of heightened inflammation under some conditions.
Mechanisms: epigenetics and metabolism
Mihai G. Netea of Radboud University Medical Center and colleagues described how brief exposures to certain microbial stimuli induce persistent changes in chromatin marks at promoters and enhancers of inflammatory genes. These alterations, including increased activating histone marks, make cytokine genes more accessible so that subsequent unrelated stimuli elicit stronger transcriptional responses. Netea emphasized that this is not classical adaptive memory but a functional reprogramming of innate cells and their bone marrow progenitors. Metabolic remodeling accompanies the epigenetic changes; shifts toward glycolysis and altered mitochondrial function supply substrates for chromatin-modifying enzymes and sustain enhanced effector functions.
Evidence and ecological nuances
Clinical and epidemiological evidence supports meaningful consequences. T. Kleinnijenhuis of Radboud University Medical Center reported that bacille Calmette-Guérin vaccination can induce trained responses in human monocytes, increasing cytokine production after unrelated challenges. Field studies led by Peter Aaby of the Bandim Health Project and collaborators documented associations between BCG vaccination and reduced all-cause infant mortality in low-income settings, suggesting real-world cross-protection beyond tuberculosis. These findings intersect with territorial and cultural practices: countries that maintain universal BCG policies may experience different patterns of early-life infectious disease than countries that stopped universal BCG, and local pathogen exposure, nutrition and healthcare access modulate outcomes.
Consequences extend to both benefit and risk. On one hand, enhanced innate responsiveness can improve early control of infections and augment vaccine effects. On the other hand, sustained pro-inflammatory priming may exacerbate autoinflammatory conditions or worsen tissue injury in certain environments. Translating trained immunity into interventions requires balancing protective cross-immunity with the potential for maladaptive inflammation, tailoring strategies to population health needs and ethical considerations in different cultural and territorial contexts. Ongoing clinical trials and mechanistic studies aim to define when and how trained innate immunity can be harnessed safely.